
SNY

Sanofi (SNY) Latest News & Updates
Explore latest Sanofi (SNY) News and Updates
Stay updated on Sanofi (SNY) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in Sanofi (SNY)
Order type
Buy in
Order amount
Est. shares
0 shares





GlobeNewsWire •

Reuters •



InvestorPlace •



GlobeNewsWire •


InvestorPlace •




The Motley Fool •

Press Release: Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)
GlobeNewsWire •

InvestorPlace •

24/7 Wall Street •


Market Watch •

Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency
Business Wire •

Explore latest Sanofi (SNY) News and Updates
Stay updated on Sanofi (SNY) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in Sanofi (SNY)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.